Arkolith/Insider Trading/KURA/Form 4

Powl Brian T.

Chief Commercial OfficerKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Jan 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$54K
Net Open-Market Flow
-$54K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2026Sell(S)2K$8.46$13K183K
Jan 27, 2026Sell(S)5K$8.46$41K185K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-025305) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML